National Cancer Institute Awards Masonic Cancer Center "Outstanding" Rating

The University of Minnesota Masonic Cancer Center (MCC) has been awarded an outstanding rating by the National Cancer Institute (NCI). The rating represents its highest rating to date. MCC also renewed its five-year Cancer Center Support Grant, which allows the center to continue its groundbreaking research in the areas of cancer, cancer prevention, survivorship, tobacco control research, and innovative strategies to treat cancer including immuno- and cellular therapies. 

The NCI has 70 NCI-Designated Cancer Centers across the nation. Since 1998, the Masonic Cancer Center has been the only one in the Twin Cities and continues to be a national leader in cancer research and patient care.

“As cancer physicians and researchers, our goal is to change cancer in the same way tuberculosis was changed a generation ago,” said Jakub Tolar, MD, PhD, Dean of the Medical School. “We achieve this by combining innovation and care delivery in a way that improves the outcomes of the disease. The continued success of the Masonic Cancer Center shows the value of our work, as well as the skill and expertise we offer in cancer research, prevention, and treatment.”

Share this post

Related News

  • Transplant Expert Becomes Transplant Minnesotan

    Andrew Adams, MD, PhD, has joined the Department of Surgery as a professor and as chief of the Division of Transplantation at both M Health Fairview University of Minnesota hospitals. He brings $11.7 million in funding from the National Institutes of Health focused on developing novel therapies to improve outcomes for transplant patients.

  • Study Analyzes if Telemedicine is Efficacious in Treating Opioid Use Disorder

    Federal and state agencies have temporarily allowed unprecedented flexibility for the use of telemedicine, including audio-only visits, for encounters where opioid use disorder (OUD) medications are prescribed. Cuong Pham, MD, an assistant professor in the Department of Medicine, is analyzing telemedicine’s efficacy for patients with OUD during COVID-19.

  • Researchers Study Cortisol Levels, Decision-Making in COVID-19 Healthcare Workers

    Alexander Herman, MD, PhD, in the Department of Psychiatry and Behavioral Sciences, and David Darrow, MD, MPH, in the Department of Neurosurgery, are studying hair samples from frontline healthcare workers during the COVID-19 pandemic to determine how their cortisol levels might correlate with their responses on a multi-armed bandit task.”